Crypto and Cures: How Enlivex is Betting on RAIN and Osteoarthritis Relief!
The clinical-stage company, famous for its joint-elixir Allocetra, has been busy garnering funds for its digital asset treasure hunt. Last year’s $212 million private equity affair has paved the way for a strategy involving prediction markets, because apparently guessing what will happen next is all the rage nowadays.






